When CO2 is added to the inspired gas of a normal resting subject, the PCO2 of arterial blood rises quickly, but the ventilation rate increases gradually. The lag of ventilation behind change in arterial Pco2 has been ascribed to the time required for the tissues of the respiratory center to come into balance with the altered Pco2 of the perfusing blood (1-3). The response of ventilation to change in arterial Po2 is more prompt, presumably because the peripheral chemoreceptors are more richly perfused (2, 4-7). These relationships have been well established, but there is little information about factors which can affect the rate at which ventilation responds to a bloodborne stimulus.
When CO2 is added to the inspired gas of a normal resting subject, the PCO2 of arterial blood rises quickly, but the ventilation rate increases gradually. The lag of ventilation behind change in arterial Pco2 has been ascribed to the time required for the tissues of the respiratory center to come into balance with the altered Pco2 of the perfusing blood (1) (2) (3) . The response of ventilation to change in arterial Po2 is more prompt, presumably because the peripheral chemoreceptors are more richly perfused (2, (4) (5) (6) (7) . These relationships have been well established, but there is little information about factors which can affect the rate at which ventilation responds to a bloodborne stimulus.
It is possible to produce an abrupt increase in arterial Pco2, as well as other arterial blood changes, by releasing tourniquets which have occluded blood flow through the legs for several minutes (8) (9) (10) (11) . A few seconds after the rise in arterial PCO2 begins, there is an abrupt increase in ventilation rate ( Figure 1 ). It is found that the time of onset and the magnitude of this ventilation increase can be markedly altered by a variety of procedures which also have the common property of changing the rate of cerebral blood flow. It is, however, difficult to explain all of the observations satisfactorily in terms of our present understanding of the control of ventilation. It is the purpose of this report to present data on the production and modification of tourniquet hyperpnea with particular reference to apparent variations in the stimulus-response time of ventilation, and to speculate on the meaning of these data.
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METHODS
The subj ects were untrained normal male medical students with an age range of 21 to 31 years. They were not fasting and came to the experiment directly from their work.
In outline, the technique consisted of occluding circulation to the legs for 15 minutes by applying arterial tourniquets to the thighs and then releasing the tourniquets suddenly while the subj ect was breathing into a recording spirometer. Multiple arterial blood samples were withdrawn from an indwelling brachial artery needle before and after tourniquet release for analysis of the pH, CO2, and 02 changes produced by this procedure.
In detail, the experimental procedure was as follows. The subj ect was placed in the supine position and a Cournand needle was inserted into a brachial artery. The needle was attached by plastic tubing to a manifold with a series of three-way stopcocks to which syringes were attached for rapid withdrawal of small blood samples. Wrap-around blood pressure cuffs, 8 inches in width, were placed on the upper thighs. The cuffs were inflated rapidly to a pressure above the arterial systolic pressure by releasing a clamp on the tubing between the cuffs and a 15-L carboy into which air had previously been compressed to over 300 mm Hg. The pressure in the cuffs was maintained at 180 to 200 mm Hg (well over systolic pressure in all subjects) for the entire 15-minute period that the tourniquets were applied. During this period, subjects avoided any muscular activity below the tourniquets. Almost all subjects complained of some aching or cramping sensations in the legs, particularly underneath the tourniquets, for the first 3 to 5 minutes after cuff inflation. During the remainder of the 15-minute period, however, all subjects were relaxed and had little or no discomfort from the tourniquets. During the last 5 minutes of tourniquet application and the period after tourniquet release, subjects breathed from a 150-L Douglas bag through a Douglas valve into a 120-L recording spirometer so that the ventilation rate could be continuously recorded. It is reported as ventilation at ATPS. Ventilation was recorded after tourniquet release until the rate had returned to the prerelease level. When the cuffs had been inflated for 15 minutes, they were released suddenly by opening an escape valve. At the time of tourniquet release, subj ects experienced a brief sensation of tingling which generally subsided well 269 before any ventilatory response occurred. Arterial blood samples were taken immediately prior to tourniquet release and at regular intervals for 1.5 to 2 minutes after tourniquet release. Each sample was withdrawn rapidly over a few seconds' time. Each sampling time reported is the midpoint of the sampling period. Blood was taken into oiled, heparinized syringes. For pH determinations, sodium fluoride was added as a preservative. The syr- inges were capped and stored in ice water and analyses were completed within 2 to 5 hours.
This entire procedure was carried out at least twice in every subject studied, once with air and once with tank oxygen (99.5 per cent) as the gas inspired from the Douglas bag during the last 5 minutes of tourniquet application and the period following tourniquet release. The order in which the studies were done was randomized from subject to subject, and the subjects did not know which gas was being breathed. In some subjects, this entire procedure was carried out under other special conditions described below.
In 5 subj ects, the procedure was repeated with both air and oxygen breathing during sodium bicarbonate infusion. The subjects were given 400 to 500 ml of 3.0 per cent NaHCO, intravenously over a 30-minute period before tourniquet release. Three additional subjects were studied during NaHCO2 infusion with 3.0 per cent CO2, 21.0 per cent 02, 76.0 per cent N2, and 3.0 per cent CO2, 97 per cent 02 as the inspired gases.
Three subj ects were studied during ammonium chloride infusion. These subj ects were given approximately 200 ml of 0.8 per cent NH4CI intravenously over a 30-minute period before tourniquet release on air and an additional 150 ml in the next 30 minutes before tourniquet release while they breathed oxygen.
In another 5 subjects, the procedures were carried out during aminophylline infusion. The subjects were given 300 mg of aminophylline by infusion into an arm vein during the 30 minutes before tourniquet release on air and an additional 300 mg during the following 30 minutes before tourniquet release while they breathed oxygen.
In 7 subjects tourniquets were not used, but ventilation was recorded continuously during the first 6 minutes of breathing two different gas mixtures containing approximately 4.5 per cent CO2, 21 15 minutes was allowed between trials. The order of presenting the two mixtures was varied. Switching from control to the C02-containing mixture without the subjects' knowledge required an arrangement with extra lead-in tubing, so that an average of about 8 seconds was needed for the gas actually to reach the subject. Arterial samples were taken as above, without disturbing the subject, during the control period and usually at 1 minute and 6 minutes after switching to CO2.
The arterial blood oxygen capacity was determined by the method of Drabkin and Austin (12). Oxygen content and per cent oxygen saturation were determined by the spectrophotometric method of Hickam and Frayser (13) Tables I and II. sure changes on air and oxygen breathing were similar. The time required for appearance of hyperpnea, as well as the lack of obvious neurogenic stimuli to account for its onset, indicates its mediation by a blood-borne stimulus arriving at the respiratory center or peripheral receptors. The effects of breathing air and oxygen on tourniquet hyperpnea and on the time course of arterial blood gas changes were compared in seven subjects. The effect of tourniquet release on ventilation in these subjects is summarized in Table I. Table II presents the mean values for arterial CO2 content, Pco2, and pH in these seven subjects. About 10 seconds were required to collect a blood sample and the sampling time from which the means were calculated was the midpoint of the sampling period. From the table, and from Figure 2 , which shows the change in arterial Pco2, it is apparent that the CO2 and pH changes were similar on air and oxygen, except that the changes with air came significantly earlier than those with oxygen. Inspection of Figure 2 indicates that the period of rapid increase in arterial PCo2 developed roughly 7 seconds sooner after tourniquet release when the subject was breathing air than when he was breathing oxygen. The slight delay in arterial blood change on oxygen is at least partially explained by the finding that the cardiac output is slightly lower and the mean circulation time longer after tourniquet release with oxygen breathing than with air breathing (18) . However, the difference in timing of the apparent ventilation stimulus, so far as this is indicated by Pco2 change, accounts for only a small part of the delay in ventilation response while breathing oxygen; that is, for approximately 7 seconds of a 27-second difference in response time. Furthermore, hyperpnea developed in the air-breathing group at a much lower Pco2 level than with oxygen breathing. Measurements were also made of arterial blood oxygen saturation: on air, the mean control value was 96.8 per cent, and the greatest change was -2.2 ± 2.1 per cent at the 37-second sampling period; with oxygen breathing, saturation remained at 100 per cent. In six subjects a comparison was made of the timing of tourniquet hyperpnea while they breathed 15 per cent 0,2 85 per cent N2, and of that while they breathed air. Arterial blood samples were taken at only two times, before tourniquet release and immediately after the onset of hyperpnea. In this series, the interval between tourniquet release and hyperpnea was 28 ± 4 seconds on air and 23 ± 4 seconds on 15 per cent oxygen; this time difference was significant (p < 0.01). On air, the change in arterial oxygen saturation after hyperpnea began was -1.6 + 0.8 per cent, and on 15 per cent oxygen it was -3.3 + 1.0 per cent, a significant difference (p < 0.05). The increase in arterial Pco2 on air was 4.7 + 2.9 mm Hg, and on 15 per cent oxygen, 1.1 ± 2.0 mm Hg, but the difference was not statistically significant.
Oxygen causes cerebral vasoconstriction, and if this effect were pronounced in the respiratory center it might account for the delay in tourniquet hyperpnea caused by oxygen. Accordingly, observations were made on the effect of other agents that alter cerebral blood flow.
Inhalation of CO2 (19) (20) (21) and intravenous infusion of 3.0 per cent NaHCO3 (20) both increase cerebral blood flow. Eight subjects were given infusions of NaHCO3, and three of these also breathed 3 per cent CO2 in air during study.
The results in the two groups were similar. The combined data are presented in Table III . The effect of CO,, NaHCO3, or both was to reduce significantly the interval between tourniquet release and the onset of hyperpnea during oxygen breathing.
NH4C1 infusion decreases cerebral blood flow I Significantly different from oxygen alone (p < 0.01). (20) . The results of NH4C1 infusion in three release and hyperpnea was prolonged during subjects are shown in Table IV . One subject NH4C1 infusion in all three subjects, both on air had hyperventilation with NH4C1 infusion and and oxygen. In one subject, hyperpnea after resultant alkalosis. The other two subjects tourniquet release did not occur at all with oxygen had decrease in pH with air breathing and breathing during NH4C1 infusion. The ventilaNH4Cl. The interval between tourniquet tion increment after tourniquet release was de- t Calculated from 2 subjects only since 1 subject had no hyperpneic response. creased by NH4Cl in all three subjects during air at high oxygen tensions (25, 26) , increases in breathing and in two of three subjects on oxygen. ventilation over the control level are expressed
The intravenous infusion of 500 mg of ami-as per cent of the ventilation increment that each nophylline is reported to decrease cerebral blood subject attained on the appropriate gas mixture flow by 25 to 35 per cent (22) (23) (24) . As shown in after 6 minutes. Ventilation increased much Table V , five subjects had a significant prolonga-more slowly on 95 per cent 02 than on 21 per tion of the interval between tourniquet release and cent 02 during the first minute, after which the hyperpnea when given aminophylline during air two ventilation-time curves were roughly parallel, breathing. With oxygen breathing, the interval with the high oxygen curve always lagging. In each trial of CO2 breathing the Pco2 of the early and late arterial blood samples was remarkably constant. Of all 14 of these pairs, the greatest difference between early and late members of a pair was 3.0 mm Hg. In summary, breathing the two gas mixtures caused a prompt, substantially equal elevation in arterial Pco2, but ventilation increased much more slowly on 95 per cent 02 than on 21 per cent 02.
DISCUSSION
The identity of the primary stimulus responsible for tourniquet hyperpnea and the site of its action are not entirely clear. Mills (27) has reported that release of venous tourniquets will produce a very brief, mild hyperpnea in approximately 4 seconds, possibly related to an acute increase in pulmonary blood volume. The present tourniquet hyperpnea, produced by release of arterial tourniquets, is different in timing, quantity, and duration. The stimulus for this tourniquet hyperpnea, for reasons given earlier, appears to be blood-borne. The change in arterial blood oxygen after tourniquet release with the subject breathing air or 15 per cent oxygen seems too little to account for the hyperpnea. The increase in arterial Pco2 and the associated pH change could easily account for the increase in ventilation, given enough time to act. However, the prompt appearance of the hyperpnea and the abruptness with which it reaches full magnitude are not typical of the ventilatory response to inhaled CO2.
Grodins and co-workers (3) (1-3) . By contrast, during air breathing, tourniquet hyperpnea, which almost immediately reached 5 L per minute, appeared at 23 seconds after cuff release, when the mean elevation of arterial Pco2 was only about 3 mm Hg. At this time the arterial Po02 could hardly have been rising for more than 10 seconds. If the slow response to inhaled CO2 depends primarily on the time required for perfusing blood to raise the CO2 of the respiratory center, and if tourniquet hyperpnea also results from increased CO2 in the center, then it seems necessary to postulate that the tourniquet maneuver may in some way have the effect of greatly increasing blood flow through the center. This could perhaps account for the promptness with which tourniquet hyperpnea appears. Increased sensitivity to CO2 seems an unlikely explanation since tourniquet hyperpnea quickly levels off even though arterial Pco2 continues to rise for a few seconds more.
The effect of oxygen in delaying tourniquet hyperpnea and decreasing the response might result from a decrease in sensitivity to Pco2 change, a reduction in blood flow through the center, or both. It is well established that the ventilatory response to inhaled CO2 is diminished by high oxygen tensions. The effect of oxygen on the speed of response to inhaled CO2 has received little notice, except by White, Humm, Armstrong and Lundgren (25) , who observed that ventilation increases more slowly when CO2 is given in oxygen than when it is given in air. (19) found a mean decrease of 13 per cent in the cerebral blood flow on 85 per cent oxygen, but calculations based on assumptions similar to those of Grodins and associates (3) suggest that blood flow through the center would have to be reduced by about 50 per cent to account for the effect of oxygen on the response rate to inhaled CO2 (see Appendix).
An attempt has also been made to calculate how much change in center flow would be needed to account for the effect of oxygen on tourniquet hyperpnea (see Appendix). Here, even more assumptions are needed because of the constantly changing arterial Pco2. The results'indicate that a flow reduction to about one-fourth on oxygen might account for the effect. However, the absolute value of flow during tourniquet hyperpnea would need to be several times greater than that during CO2 inhalation. This conclusion is also grossly apparent from the comparative data already presented.
In summary, it appears that accounting for the differences in rate of response to tourniquet hyperpnea and to inhaled CO2 during air and oxygen breathing by postulating changes in perfusion rate of the respiratory center would require that perfusion of the center be markedly reduced by oxygen and markedly increased during the tourniquet procedure, possibly by substances released from hypoxic extremities. This would be facilitated by rich vascularization of this region. Histologic studies do, in fact, show great variation in the concentration of capillaries in different parts of the brain. The brain stem is among those regions which appear to be most richly supplied with capillaries (28, 29) .
In order to explore further the possibility that changing perfusion rates of the respiratory center might influence the timing of tourniquet hyperpnea, observations were made on the effect of procedures known to alter over-all cerebral blood flow. Aminophylline and NHCl, which decrease cerebral blood flow, each significantly delayed the appearance of hyperpnea on air, and NHCl probably augmented the delay produced by oxygen. NaHCO3 with CO2, which increases cerebral flow, significantly decreased the delay on oxygen, but did not affect the interval during air breathing. Multiple arterial pH determinations on several subjects did not show any effect of these procedures on the timing of arterial blood changes following tourniquet release. These observations are consistent with the hypothesis that the interval between tourniquet release and hyperpnea is related to the rate of cerebral blood flow, but are also open to other interpretations.
From the present data it is not possible to exclude participation of the peripheral chemoreceptors in the phenomena of tourniquet hyperpnea.
The carotid body is stimulated by a rise in Pco2 and a fall in pH, although the effect is much less than that produced by hypoxia (2, 30, 31) . It is richly perfused (5), and its perfusion rate appears to be altered markedly by change in oxygen tension of the blood (6). Evidence is not available, however, to indicate whether the various agents used here to change cerebral blood flow also affect carotid body perfusion in the same directions.
It is conceivable that chemical stimulation of the carotid body might account for the rapid occurrence of tourniquet hyperpnea during air breathing and that a high arterial oxygen tension might suppress the stimulus, as it can suppress the cyanide stimulus (7) . The delayed response on oxygen would then represent the slower response of the respiratory center, now unmasked by removal of the carotid body stimulus. This postulate, however, would raise problems relating to the oxygenlike effects of aminophylline and ammonium chloride, and the opposing effect of bicarbonate.
The possibility also remains that some unidentified substance which is a respiratory stimulant may be released from the ischemic extremities and account for tourniquet hyperpnea. ' The release of such a substance from working muscles,'has been suggested to explain the hyperpnea" of exercise (32, 33) .
There is a striking parallelism between the course of blood changes and ventilation early in exercise and in tourniquet hyperpnea. With the onset of moderately severe exercise in unconditioned subjects there is an immediate increase in ventilation (34), presumably "neurogenic" in origin. This persists nearly unchanged in most subjects for 40 to 60 seconds, despite the development of a considerable increase in arterial Pco2 toward the end of this period. There is then an abrupt "secondary" increase in ventilation which appears to be a response to the change in arterial blood (35, 36) . The abruptness of this response is reminiscent of tourniquet hyperpnea. In both exercise and tourniquet hyperpnea the arterial Pco2 is elevated for a few seconds before the response. In both cases large masses of hypoxic muscle are being perfused. Recently, Craig and Cummings (37) have shown that the "secondary" rise of ventilation during exercise develops much more gradually when subjects are breathing oxygen than when they are breathing air. These findings suggest that tourniquet hyperpnea and the "secondary" rise of ventilation early in exercise may be closely related phenomena.
Although the identity of the principal ventilatory stimulus in tourniquet hyperpnea and the site of its action are not yet clearly established, it is evident that the timing and magnitude can be greatly altered by procedures which also alter the rate of cerebral blood flow. The effect of changing perfusion rates in chemosensitive regions must be taken into account in the study of states characterized by a rapidly changing ventilation (38 3. It is concluded that the rate at which ventilation responds to an increase in arterial PCo2, and possibly to other blood-borne stimuli, can be slowed considerably by procedures which reduce cerebral blood flow and increased by procedures which increase cerebral flow. However, in order to account for the timing of tourniquet hyperpnea simply by change in the CO2 content of the respiratory center, it is necessary to postulate that the center is much more rapidly perfused during tourniquet hyperpnea than during CO2 inhalation, and that its perfusion rate is remarkably altered by oxygen and by some other substances which alter the over-all cerebral blood flow.
APPENDIX
If it be assumed that the ventilatory response to inhaled CO2 and to tourniquet release depends upon changes in the Pco2 of the respiratory center, the present data, together with certain further assumptions, permit making estimates of the perfusion rate of the center. Because the assumptions are necessarily inaccurate, the estimates are not advanced as having quantitative validity in absolute terms. Nevertheless, the calculations are useful because proportionate changes in estimated perfusion rates under different circumstances are so great as to indicate either a quite unexpected capacity for altering flow in the center, or a failure to take into account some other, apparently unfamiliar, regulatory mechanism.
The basic assumptions are as follows : 1) [1] [2]
In order to obtain a value for the turnover rate, k, a value for C at a time, t, must be obtained, using In the case of tourniquet hyperpnea, B, the arterial PCo2, is changing rapidly during -the ventilatory response and it is desirable to choose a simple function of time which describes B in approximate terms. For this purpose let B = 7 sin (ir/60) t. This curve is plotted in Figure 3 . The actual first 3 mean values for increase in arterial Pco2 after tourniquet release on air and on oxygen, shown in Figure 2 , are also plotted in Figure 3 to demonstrate their agreement with the hypothetical arterial curve, at least up to 40 seconds from the beginning of increase in Pco2. Time in Figure 3 begins with the increase in arterial Pco2, which is estimated from the data of Figure 2 to begin at 13 seconds after tourniquet release on air and 20 seconds after release on oxygen. Accordingly, these intervals are subtracted from the times given in Table II and Figure 2 to yield the times shown in Figure 3 . The agreement is considered satisfactory as an approximate description of B. [3] responding to I mm Hg increments in Pco2 of the center at indicated intervals after onset of arterial blood changes * [4] K, the integration constant, is evaluated by setting C = 0 when t = 0, yielding C 7k [k sin (r/60)t -7r/60 cos (r/60) t + w/60e-kt] k2 + (7/60)2
In Figure 3 this function is plotted to show how C would vary with t, given the same arterial Pco2 curve but different perfusion rates of the center, represented by different values of k. Figure 3 illustrates some relationships which follow from acceptance of the hypotheses that variations in perfusion rate principally account for variations in response time and that the simple model just described usefully simulates reality.
If tourniquet hyperpnea is assumed to result simply from increase in Pco2 of the respiratory center, then a rapid perfusion rate must be postulated. Since tourniquet hyperpnea on air begins abruptly at a rate not much under 5 L per minute and shortly exceeds that, it is a conservative choice to assign 2 mm Hg as the increase in center Pco, at the onset of hyperpnea. Table VII presents the k values corresponding to increments of 1, 2, and 3 mm Hg Pco2 in the respiratory center at various intervals after the onset of arterial blood changes. When the interval is taken to be 10 seconds, as in the seven subjects of Tables I and II, a k of 0.20 is required for a Pco2 of 2 mm Hg. Allowing an interval of 15 seconds, to correspond with the slightly longer response time of most subjects, still yields a k of 0.08.
To account for the change in response time on oxygen within the limitations of the present assumptions, a marked reduction in perfusion rate must be postulated. If a 2 mm Hg increase in Pco2 again is taken as the response "threshold," the k value appropriate to the 30-second response time on oxygen is 0.02 (Table VII) . This perfusion rate is only one-fourth as large as that occurring on air by the more conservative estimate. It may also be noted that a reduction in k of this degree has the effect of reducing considerably the maximal increase which occurs in Pco2 of the center and delaying the time at which this maximum comes.
It is reiterated that these "perfusion rates" cannot be advanced as representing the actual perfusion rate of the "respiratory center." The calculations emphasize, however, that acceptance of the postulate that changes in Pco2 of the center can account for both tourniquet and CO2 inhalation hyperpnea, and acceptance of the simple model presented here, impose an apparent need to accept also that oxygen inhalation reduces center flow proportionately much more than over-all cerebral flow, and that center flow is considerably greater during tourniquet hyperpnea than during CO2 inhalation. The need for further investigation of the subject is apparent.
